Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
| Product: | Fasenra |
| Active Ingredient: | Benralizumab 30mg/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | AstraZeneca Limited |
| Manufacturers: | AstraZeneca Pharmaceuticals LP, Maryland, United States of America Catalent Indiana LLC, Indiana, United States of America |
| Product: | Oncaspar |
| Active Ingredient: | Pegaspargase 750U/mL |
| Dosage Form: | Solution for injection |
| New Zealand Sponsor: | Servier Laboratories Limited |
| Manufacturer: | Exelead Inc, Indiana, United States of America |
| Product: | Paracare Paracetamol + Ibuprofen (General sale) |
| Active Ingredients: | Ibuprofen 200mg Paracetamol 500mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | PSM Healthcare Limited trading as API Consumer Brands |
| Manufacturer: | Medreich Limited, Bangalore, India |
Dated this 10th day of February 2020.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).